177 related articles for article (PubMed ID: 38194089)
21. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
[TBL] [Abstract][Full Text] [Related]
22. Emerging antiresorptive medications and their potential implications for dental surgeries.
Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D
J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242
[TBL] [Abstract][Full Text] [Related]
23. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
24. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
Soutome S; Otsuru M; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Kojima Y; Sawada S; Iwai H; Umeda M; Saito T
Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
[TBL] [Abstract][Full Text] [Related]
25. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Osteonecrosis of the Jaw.
Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
[TBL] [Abstract][Full Text] [Related]
27. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
Sacco R; Umar G; Guerra RC; Akintola O
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
[TBL] [Abstract][Full Text] [Related]
29. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
Neal TW; Schlieve T
J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181
[TBL] [Abstract][Full Text] [Related]
30. Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
Ikesue H; Mouri M; Tomita H; Hirabatake M; Ikemura M; Muroi N; Yamamoto S; Takenobu T; Tomii K; Kawakita M; Katoh H; Ishikawa T; Yasui H; Hashida T
Support Care Cancer; 2021 Aug; 29(8):4763-4772. PubMed ID: 33527228
[TBL] [Abstract][Full Text] [Related]
31. Imaging findings and treatment outcomes of a rare subtype of medication-related osteonecrosis of the jaw.
Otsuru M; Soutome S; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Umeda M
J Bone Miner Metab; 2022 Jan; 40(1):150-156. PubMed ID: 34510261
[TBL] [Abstract][Full Text] [Related]
32. Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?
Fleisher KE; Pham S; Raad RA; Friedman KP; Ghesani M; Chan KC; Amintavakoli N; Janal M; Levine JP; Glickman RS
J Oral Maxillofac Surg; 2016 May; 74(5):945-58. PubMed ID: 26657395
[TBL] [Abstract][Full Text] [Related]
33. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
[TBL] [Abstract][Full Text] [Related]
34. The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: A 12-year retrospective study of 129 patients.
Kaibuchi N; Hoshi K; Yamazaki A; Miyamoto-Sangu N; Akagi Y; Okamoto T
Bone Rep; 2021 Jun; 14():101072. PubMed ID: 33997149
[TBL] [Abstract][Full Text] [Related]
35. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
Otto S; Aljohani S; Fliefel R; Ecke S; Ristow O; Burian E; Troeltzsch M; Pautke C; Ehrenfeld M
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34065104
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw.
Otsuru M; Soutome S; Omori K; Suyama K; Morishita K; Hayashida S; Murata M; Takagi Y; Sasaki M; Sumi M; Kojima Y; Sawada S; Sakamoto Y; Umeda M
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457491
[TBL] [Abstract][Full Text] [Related]
37. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M; Kuroshima S; Sawase T
Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of Medication-Related Osteonecrosis of the Jaw: Odontogenic Infection-Preceding Type and Osteonecrosis-Preceding Type.
Sakamoto Y; Sawada S; Kojima Y
Cureus; 2024 May; 16(5):e60223. PubMed ID: 38868238
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Medication-Related Osteonecrosis of the Jaws without Segmental Resections: A Case Series.
Fernandes TL; Viezzer Fernandes B; Franco GCN
Am J Case Rep; 2024 Feb; 25():e942980. PubMed ID: 38404023
[TBL] [Abstract][Full Text] [Related]
40. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
Wick A; Bankosegger P; Otto S; Hohlweg-Majert B; Steiner T; Probst F; Ristow O; Pautke C
Clin Oral Investig; 2022 Mar; 26(3):2839-2852. PubMed ID: 34812959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
